Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins

Abstract Acute lung injury (ALI) leads to progressive loss of breathing capacity and hypoxemia, as well as pulmonary surfactant dysfunction. ALI’s pathogenesis and management are complex, and it is a significant cause of morbidity and mortality worldwide. Exogenous surfactant therapy, even for resea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ann M. Czyzewski, Lynda M. McCaig, Michelle T. Dohm, Lauren A. Broering, Li-Juan Yao, Nathan J. Brown, Maruti K. Didwania, Jennifer S. Lin, Jim F. Lewis, Ruud Veldhuizen, Annelise E. Barron
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5a096b460ffa43f2a9f1d30deb079393
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5a096b460ffa43f2a9f1d30deb079393
record_format dspace
spelling oai:doaj.org-article:5a096b460ffa43f2a9f1d30deb0793932021-12-02T15:08:39ZEffective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins10.1038/s41598-018-25009-32045-2322https://doaj.org/article/5a096b460ffa43f2a9f1d30deb0793932018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25009-3https://doaj.org/toc/2045-2322Abstract Acute lung injury (ALI) leads to progressive loss of breathing capacity and hypoxemia, as well as pulmonary surfactant dysfunction. ALI’s pathogenesis and management are complex, and it is a significant cause of morbidity and mortality worldwide. Exogenous surfactant therapy, even for research purposes, is impractical for adults because of the high cost of current surfactant preparations. Prior in vitro work has shown that poly-N-substituted glycines (peptoids), in a biomimetic lipid mixture, emulate key biophysical activities of lung surfactant proteins B and C at the air-water interface. Here we report good in vivo efficacy of a peptoid-based surfactant, compared with extracted animal surfactant and a synthetic lipid formulation, in a rat model of lavage-induced ALI. Adult rats were subjected to whole-lung lavage followed by administration of surfactant formulations and monitoring of outcomes. Treatment with a surfactant protein C mimic formulation improved blood oxygenation, blood pH, shunt fraction, and peak inspiratory pressure to a greater degree than surfactant protein B mimic or combined formulations. All peptoid-enhanced treatment groups showed improved outcomes compared to synthetic lipids alone, and some formulations improved outcomes to a similar extent as animal-derived surfactant. Robust biophysical mimics of natural surfactant proteins may enable new medical research in ALI treatment.Ann M. CzyzewskiLynda M. McCaigMichelle T. DohmLauren A. BroeringLi-Juan YaoNathan J. BrownMaruti K. DidwaniaJennifer S. LinJim F. LewisRuud VeldhuizenAnnelise E. BarronNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ann M. Czyzewski
Lynda M. McCaig
Michelle T. Dohm
Lauren A. Broering
Li-Juan Yao
Nathan J. Brown
Maruti K. Didwania
Jennifer S. Lin
Jim F. Lewis
Ruud Veldhuizen
Annelise E. Barron
Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
description Abstract Acute lung injury (ALI) leads to progressive loss of breathing capacity and hypoxemia, as well as pulmonary surfactant dysfunction. ALI’s pathogenesis and management are complex, and it is a significant cause of morbidity and mortality worldwide. Exogenous surfactant therapy, even for research purposes, is impractical for adults because of the high cost of current surfactant preparations. Prior in vitro work has shown that poly-N-substituted glycines (peptoids), in a biomimetic lipid mixture, emulate key biophysical activities of lung surfactant proteins B and C at the air-water interface. Here we report good in vivo efficacy of a peptoid-based surfactant, compared with extracted animal surfactant and a synthetic lipid formulation, in a rat model of lavage-induced ALI. Adult rats were subjected to whole-lung lavage followed by administration of surfactant formulations and monitoring of outcomes. Treatment with a surfactant protein C mimic formulation improved blood oxygenation, blood pH, shunt fraction, and peak inspiratory pressure to a greater degree than surfactant protein B mimic or combined formulations. All peptoid-enhanced treatment groups showed improved outcomes compared to synthetic lipids alone, and some formulations improved outcomes to a similar extent as animal-derived surfactant. Robust biophysical mimics of natural surfactant proteins may enable new medical research in ALI treatment.
format article
author Ann M. Czyzewski
Lynda M. McCaig
Michelle T. Dohm
Lauren A. Broering
Li-Juan Yao
Nathan J. Brown
Maruti K. Didwania
Jennifer S. Lin
Jim F. Lewis
Ruud Veldhuizen
Annelise E. Barron
author_facet Ann M. Czyzewski
Lynda M. McCaig
Michelle T. Dohm
Lauren A. Broering
Li-Juan Yao
Nathan J. Brown
Maruti K. Didwania
Jennifer S. Lin
Jim F. Lewis
Ruud Veldhuizen
Annelise E. Barron
author_sort Ann M. Czyzewski
title Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
title_short Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
title_full Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
title_fullStr Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
title_full_unstemmed Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
title_sort effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/5a096b460ffa43f2a9f1d30deb079393
work_keys_str_mv AT annmczyzewski effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT lyndammccaig effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT michelletdohm effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT laurenabroering effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT lijuanyao effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT nathanjbrown effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT marutikdidwania effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT jenniferslin effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT jimflewis effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT ruudveldhuizen effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
AT anneliseebarron effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins
_version_ 1718388060516777984